Advanced statistical methods and designs for clinical trials for COVID-19
- PMID: 33408032
- PMCID: PMC7833547
- DOI: 10.1016/j.ijantimicag.2020.106167
Advanced statistical methods and designs for clinical trials for COVID-19
Comment in
-
Response to advances statistical methods and designs for clinical trials for COVID-19.Int J Antimicrob Agents. 2021 Jan;57(1):106235. doi: 10.1016/j.ijantimicag.2020.106235. Int J Antimicrob Agents. 2021. PMID: 33408028 Free PMC article. No abstract available.
References
-
- Harding R. Cuomo: NY to conduct drug trials for coronavirus treatment. (Mar 22, 2020) https://auburnpub.com/news/local/govt-and-politics/cuomo-ny-to-conduct-d....
-
- Wang W. On construction of the smallest one-sided confidence interval for the difference of two proportions. The Annals of Statistics. 2010;38:1227–1243.
-
- Shan G., Wang W. ExactCIdiff: an R package for computing exact confidence intervals for the difference of two proportions. The R Journal. 2013;5(2):62–71.
-
- Zhao J., Yang Y., Huang H.P., Li D., Gu D.F., Lu X.F., Zhang Z., Liu L., Liu T., Liu Y.K., He Y.J. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. medRxiv. January 2020
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
